Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients

被引：1
|
作者：
Sriram, Krishna [1 ]
Insel, Paul A. [1 ,2 ]
机构：
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
来源：
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 2020年 / 319卷 / 01期
关键词：
D O I：
10.1152/ajplung.00262.2020
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：L37 / L38
页数：2
相关论文
共 50 条
  • [41] Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study
    Lafaurie, Margaux
    Martin-Blondel, Guillaume
    Delobel, Pierre
    Charpentier, Sandrine
    Sommet, Agnes
    Moulis, Guillaume
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (01) : 194 - 203
  • [42] Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
    Aamodt, Anne Hege
    Bjork, Marte H.
    Tronvik, Erling A.
    Buanes, Eirik Alnes
    Stovner, Lars Jacob
    Atar, Dan
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (09) : 859 - 860
  • [43] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    [J]. ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
  • [44] Impact of Angiotensin Converting Enzyme Inhibitors/angiotensin Receptor Blockers on Mortality and Severity of Covid-19 Pneumonia
    Aggarwal, Ankita
    Jain, Anubhav
    Goel, Mishita
    Tusha, Jurgena
    Khanam, Verisha
    Bidhan, Sourabh
    Khan, Ameer
    Dhawan, Monica
    Tegeltija, Vesna
    Kumar, Sarwan
    [J]. CIRCULATION, 2020, 142
  • [45] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
    Ateya, Areej Mohamed
    Sabri, Nagwa A.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1873 - 1874
  • [46] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [47] Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19
    Khera, Rohan
    Clark, Callahan
    Lu, Yuan
    Guo, Yinglong
    Ren, Sheng
    Truax, Brandon
    Spatz, Erica S.
    Murugiah, Karthik
    Lin, Zhenqiu
    Omer, Saad B.
    Vojta, Deneen
    Krumholz, Harlan M.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (13):
  • [48] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
    Cure, Erkan
    Cure, Medine Cumhur
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 349 - 350
  • [49] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients
    Huang, Linna
    Chen, Ziying
    Ni, Lan
    Chen, Lei
    Zhou, Changzhi
    Gao, Chang
    Wu, Xiaojing
    Hua, Lin
    Huang, Xu
    Cui, Xiaoyang
    Tian, Ye
    Zhang, Zeyu
    Zhan, Qingyuan
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [50] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
12345